|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 scountries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen Y, Lian G, Ou G, Yang K, Chen J, Li
H, Chen S, Li J, Zeng L and Huang K: Inverse association between
Bmi-1 and RKIP affecting clinical outcome of gastric cancer and
revealing the potential molecular mechanisms underlying tumor
metastasis and chemotherapy resistance. Gastric Cancer. 19:392–402.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu ZY, Tang JN, Xie HX, Du YA, Huang L, Yu
PF and Cheng XD: 5-fluorouracil chemotherapy of gastric cancer
generates residual cells with properties of cancer stem cells. Int
J Biol Sci. 11:284–294. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Melotte V, Qu X, Ongenaert M, van
Criekinge W, de Bruïne AP, Baldwin HS and van Engeland M: The N-myc
downstream regulated gene (NDRG) family: Diverse functions,
multiple applications. FASEB J. 24:4153–4166. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cho Y, Yoon JH, Yoo JJ, Lee M, Lee DH, Cho
EJ, Lee JH, Yu SJ, Kim YJ and Kim CY: Fucoidan protects hepatocytes
from apoptosis and inhibits invasion of hepatocellular carcinoma by
up-regulating p42/44 MAPK-dependent NDRG-1/CAP43. Acta Pharm Sin B.
5:544–553. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li T, Sun R, Lu M, Chang J, Meng X and Wu
H: NDRG3 facilitates colorectal cancer metastasis through
activating Src phosphorylation. Onco Targets Ther. 11:2843–2852.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo X, Hou N, Chen X, Xu Z, Xu J, Wang L,
Yang S, Liu S, Xu L, Chen Y, et al: High expression of NDRG3
associates with unfavorable overall survival in non-small cell lung
cancer. Cancer Biomark. 21:461–469. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tang Z, Li C, Kang B, Gao G, Li C and
Zhang Z: GEPIA: A web server for cancer and normal gene expression
profiling and interactive analyses. Nucleic Acids Res 45 (W1).
W98–W102. 2017. View Article : Google Scholar
|
|
9
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guo H, Yang S, Li S, Yan M, Li L and Zhang
H: LncRNA SNHG20 promotes cell proliferation and invasion via
miR-140-5p-ADAM10 axis in cervical cancer. Biomed Pharmacother.
102:749–757. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhao L, Li C, Liu F, Zhao Y, Liu J, Hua Y,
Liu J, Huang J and Ge C: A blockade of PD-L1 produced antitumor and
antimetastatic effects in an orthotopic mouse pancreatic cancer
model via the PI3K/Akt/mTOR signaling pathway. Onco Targets Ther.
10:2115–2126. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shen X, Gu Y, Yu S, Gong P, Mao Y, Li Y,
Zheng Y, Qiao F, Zhao Z and Fan H: Silenced PITX1 promotes
chemotherapeutic resistance to 5-fluorocytosine and cisplatin in
gastric cancer cells. Exp Ther Med. 17:4046–4054. 2019.PubMed/NCBI
|
|
13
|
Kovacevic Z and Richardson DR: The
metastasis suppressor, Ndrg-1: A new ally in the fight against
cancer. Carcinogenesis. 27:2355–2366. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lin HC, Yeh CC, Chao LY, Tsai MH, Chen HH,
Chuang EY and Lai LC: The hypoxia-responsive lncRNA NDRG-OT1
promotes NDRG1 degradation via ubiquitin-mediated proteolysis in
breast cancer cells. Oncotarget. 9:10470–10482. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Du Z, Niu S, Xu X and Xu Q:
MicroRNA31-NDRG3 regulation axes are essential for hepatocellular
carcinoma survival and drug resistance. Cancer Biomark. 19:221–230.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang W, Luo P, Guo W, Shi Y, Xu D, Zheng H
and Jia L: LncRNA SNHG20 knockdown suppresses the osteosarcoma
tumorigenesis through the mitochondrial apoptosis pathway by
miR-139/RUNX2 axis. Biochem Biophys Res Commun. 503:1927–1933.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB,
Yin DD, Kong R, Xia R, Lu KH, Li JH, et al: Lnc RNA HOTAIR
functions as a competing endogenous RNA to regulate HER2 expression
by sponging miR-331-3p in gastric cancer. Mol Cancer. 13:922014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guan YX, Zhang MZ, Chen XZ, Zhang Q, Liu
SZ and Zhang YL: Lnc RNA SNHG20 participated in proliferation,
invasion, and migration of breast cancer cells via miR-495. J Cell
Biochem. 119:7971–7981. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li C, Zhou L, He J, Fang XQ, Zhu SW and
Xiong MM: Increased long noncoding RNA SNHG20 predicts poor
prognosis in colorectal cancer. BMC Cancer. 16:6552016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen Z, Chen X, Chen P, Yu S, Nie F, Lu B,
Zhang T, Zhou Y, Chen Q, Wei C, et al: Long non-coding RNA SNHG20
promotes non-small cell lung cancer cell proliferation and
migration by epigenetically silencing of P21 expression. Cell Death
Dis. 8:e30922017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu J, Liu L, Wan JX and Song Y: Long
noncoding RNA SNHG20 promotes gastric cancer progression by
inhibiting p21 expression and regulating the GSK-3β/β-catenin
signaling pathway. Oncotarget. 8:80700–80708. 2017.PubMed/NCBI
|
|
23
|
Housman G, Byler S, Heerboth S, Lapinska
K, Longacre M, Snyder N and Sarkar S: Drug resistance in cancer: An
overview. Cancers (Basel). 6:1769–1792. 2014. View Article : Google Scholar : PubMed/NCBI
|
